Phospho flow cytometry of PBMCs in psoriasis

Summary Psoriasis is a chronic inflammatory skin disease, which affects approximately 2% of the population. Severe psoriasis is often treated by inhibition of a molecule which plays a role in psoriasis, called tumour necrosis factor, by the drug infliximab. Recently, a much cheaper variant (a biosim...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	British journal of dermatology (1951) 2018-08, Vol.179 (2), p.e100-e100
Hauptverfasser:	Aarebrot, A.K., Solberg, S.M., Davies, R., Bader, L.I., Holmes, T.D., Gavasso, S., Bryceson, Y.T., Jonsson, R., Sandvik, L.F., Appel, S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiovascular diseases Exanthema Flow cytometry Infliximab Leukocytes Monoclonal antibodies Patients Psoriasis Skin diseases Tumor necrosis factor-α Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!